VOXZOGO 0.4MG — BIOMARIN PHARM, approved 2024-11-04 (NDA214938).
3 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.